Tag Archives: CJC-1295

CJC-1295 DAC vs No-DAC (Mod GRF 1-29): Complete Comparison Guide

CJC-1295 DAC vs No-DAC (Mod GRF 1-29): The Complete Comparison Guide CJC-1295 is a synthetic analog of growth hormone-releasing hormone (GHRH) designed to stimulate endogenous GH secretion. It exists in two main research forms — with and without Drug Affinity Complex (DAC) — which differ dramatically in half-life, dosing frequency, and effect profile. This guide […]

Growth Hormone Releasing Peptides Complete Guide: GHRPs, GHRH Analogs, Mechanisms & Research (2026)

Growth Hormone Releasing Peptides Complete Guide: GHRPs, GHRH Analogs, Mechanisms & Research (2026) Growth hormone releasing peptides (GHRPs) and growth hormone releasing hormone (GHRH) analogs are a class of research peptides that stimulate the body’s natural production and release of growth hormone (GH). These peptides have been extensively studied for their potential applications in body […]

CJC-1295 + Ipamorelin Combination Complete Research Guide (2026)

CJC-1295 + Ipamorelin Combination Complete Research Guide (2026) The combination of CJC-1295 (without DAC) and Ipamorelin has become one of the most widely researched and popular peptide protocols in the growth hormone-releasing peptide (GHRP) category. This synergistic combination targets two complementary pathways—growth hormone-releasing hormone (GHRH) receptor agonism and growth hormone secretagogue receptor (GHSR) agonism—to produce […]

CJC-1295 vs Ipamorelin: Growth Hormone Peptides Comparison Guide

———–|———-|————| Aging & longevity Strong (IGF-1 elevation) Moderate Body composition Strong (lean mass, fat loss) Moderate-Strong Sleep quality Strong (pulsatile release) Moderate Recovery & repair Strong Moderate Metabolic health Strong Moderate Bone density Moderate-Strong Moderate Cognitive function Emerging research Emerging Cardiac health Research interest Research interest Dosage Protocols for Research Disclaimer: All dosage information is […]